[
  {
    "ts": null,
    "headline": "Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?",
    "summary": "Biogenâs lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.",
    "url": "https://finnhub.io/api/news?id=ef3adb4bcd126997d1f1592527ecb2afc521115bd3cda32b4212595c2984fefe",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745572551,
      "headline": "Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?",
      "id": 134077371,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2165724853/image_2165724853.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Biogenâs lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.",
      "url": "https://finnhub.io/api/news?id=ef3adb4bcd126997d1f1592527ecb2afc521115bd3cda32b4212595c2984fefe"
    }
  }
]